AstraZeneca, Figliuolo: “Impact on the vaccine campaign”

The decision to administer the AstraZeneca vaccine only to the over 60s, after the rare cases of thrombosis that have occurred in recent weeks, “will have some impact on the” vaccination plan but “I’m sure that between July and August we will be able to mitigate if not eliminate this. impact”. This was stated by the Covid emergency commissioner, Francesco Paolo Figliuolo, during a press conference, at Palazzo Chigi, together with the Minister of Health, Roberto Speranza and the Coordinator of the Cts Franco Locatelli, during which it was announced that the anti-Covid vaccine “Astrazeneca will only be used for people over 60”. Read also “Currently – he explained – there are about 3.5 million over 60s still to be vaccinated and we have to carry out the second dose, which will be with Astrazeneca only for this age group, to about 3.9 million people. the rest, under the age of 60, we will do first vaccinations and second doses with mRNA serums. There is logistical sustainability “. “The forecast is 9.5 million Astrazeneca doses between now and September, which add up to those already present, so 15 million vaccines in all. If all over 60s were to be vaccinated, including the second dose, we would use all vaccines”, Figliuolo said at the press conference, specifying that “at this moment we are smooth, with supplies if there are other hitches we will review the plans. I do not make gloomy predictions, I am convinced that by the end of September we will be able to close the game”. The vaccination campaign continues according to plan: we are doing well because 45 percent of the population has already received a dose “, said Figliuolo, specifying that we are” over 40.7 million doses “. “Since Monday we have always exceeded 550 thousand doses of vaccine per day. To date – added Figliuolo – 91.5% of those over 80, 85% of those belonging to the 70-79 and 76 groups have been vaccinated with one dose % of those who are in the 60-69 range. Overall, however, 40 million administrations have been exceeded, with 49% of Italians reached by the first dose “.